Ledger.Open graph →
SEC Form D · filed May 2, 2023

Phio Pharmaceuticals Corp

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MARLBOROUGH, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jonathan A. Freeman · Marlborough, MADirectorCurtis A. Lockshin · Marlborough, MADirectorRobert J. Bitterman · Marlborough, MAExec · DirectorRobert A. Ferrara · Marlborough, MADirectorGeert A. Cauwenbergh · Marlborough, MADirectorPatricia A. Bradford · Marlborough, MADirectorChris O. Cabbiness · Hereford, TXDirectorBill S. Stovell · Hereford, TXDirectorJoe C. Perrin · Hereford, TXDirectorR. S. Keeling · Hereford, TXDirectorJosh S. Wood · Hereford, TXExec · DirectorMatt S. Cox · Hereford, TXDirectorEric T. Kish · Commerce City, CODirectorWilliam T. Fennell · Commerce City, COExec · DirectorMatthew Coleman · Commerce City, CODirectorJohn Fox · Commerce City, CODirectorJoseph G. Lallande · Newport Beach, CADirectorAndres Garcia · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗